Camrelizumab vs Placebo With Chemotherapy as Neoadjuvant Treatment in Triple-Negative Breast Cancer
Release Date: 12/13/2024
The Sequential Organ Failure Assessment (SOFA)-2 Score
JAMA Author Interviews
SOFA-2, validated in more than 3 million intensive care unit (ICU) patients, incorporates contemporary organ support treatments, showing strong predictive validity for ICU mortality in diverse international settings. Coauthor Mervyn...
info_outline
From the JAMA Network: Acetaminophen Use in Pregnancy and Risk of Autism
JAMA Author Interviews
Epidemiologist Brian Lee, PhD, discusses his study on acetaminophen use during pregnancy and children’s risk of autism and other neurodevelopmental disorders in this interview with JAMA Deputy Editor Linda Brubaker, MD. Related Content:
info_outline
From the JAMA Network: AI-Based Analysis for Parkinsonism
JAMA Author Interviews
Delaying diagnosis of parkinsonism can mean delaying care. In a study recently published in JAMA Neurology, David Vaillancourt, PhD, and colleagues tested the ability of an AI model to differentiate between Parkinson disease and other neurodegenerative disorders when paired with MRI. He joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH to discuss. Related Content:
info_outline
Treatment of Complicated Staphylococcus aureus Bacteremia
JAMA Author Interviews
Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of...
info_outline
From the JAMA Network: Incidence and Nature of Antidepressant Discontinuation Symptoms
JAMA Author Interviews
Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content:
info_outline
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
JAMA Author Interviews
Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD. Related Content:
info_outline
Life Support and Outcomes in Patients Admitted to Intensive Care Units
JAMA Author Interviews
Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes over the past 10 years, limiting understanding of practice changes. Authors Emily Moin, MD, MBE, and Scott D. Halpern, MD, PhD, MBE, of the University...
info_outline
Increases in Invasive Group A Streptococcal Infections
JAMA Author Interviews
The incidence of invasive group A streptococcal infections has risen in the US. Similar observations have been reported in other parts of the world. Authors Joshua Osowicki, MBBS, PhD, of Murdoch Children’s Research Institute and Theresa...
info_outline
Preventive Health Care Among Adults Eligible for Lung Cancer Screening
JAMA Author Interviews
Less than 20% of patients eligible for lung cancer screening get screened in the US. A recent study examined whether adults eligible for lung cancer screening engage in screening for other types of cancer. Coauthor Chi-Fu Jeffrey Yang,...
info_outline
Cardiac Arrests During Long-Distance Running: What’s Changed?
JAMA Author Interviews
Despite increased participation in US long-distance running races, cardiac arrest incidence remains stable. Authors Jonathan Kim, MD, MSc, of Emory University, and Aaron Baggish, MD, of the University of Lausanne Switzerland, discuss the...
info_outlineTriple-negative breast cancer accounts for around 15% of breast cancers. Zhi-Ming Shao, MD, of Fudon University, joins JAMA Oncology Editor in Chief and JAMA Deputy Editor Nora Disis, MD, to discuss "Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients with Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial."
Related Content: